PRIMARY IGA NEPHROPATHY
Clinical trials for PRIMARY IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for PRIMARY IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for common kidney disease
Disease control Not yet recruitingThis early-stage study aims to test the safety and initial effects of an experimental drug called YKST02 in adults with IgA nephropathy, a common kidney disease. The trial will enroll 12 participants who still have protein in their urine despite standard treatments. Researchers w…
Matched conditions: PRIMARY IGA NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New shot aims to protect kidneys from silent disease
Disease control Not yet recruitingThis study is testing whether an experimental injection called SHR-2173 can help control IgA nephropathy, a kidney disease where protein leaks into the urine. About 84 adults with the disease will receive either the real injection or a placebo (dummy shot) for 48 weeks to see if …
Matched conditions: PRIMARY IGA NEPHROPATHY
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC